Doctor refuses to treat fibromyalgia patients and chronic pain
A doctor has issued a letter that informs his patients that he will no longer be treating chronic pain or prescribing any type of pain medication. This affects the fibromyalgia patients who rely on his practice. Dr. Mark Ibsen explains that he made the decision because another doctor was recently indicted for prescribing pain medication.
The Ravalli Republic newspaper reports that Dr. Mark Ibsen sent a letter to his patients and plans to take some time off to figure out the new direction of his medical practice. Dr. Ibsen works in Helena, and his announcement affects many patients who have grown to depend on him. The Montana doctor was one of the few physicians who was willing to help fibromyalgia patients, but a recent case has changed this.
Dr. Mark Ibsen shares that the case of Dr. Chris Christensen influenced his decision. Dr. Christensen was recently indicted for prescribing pain medication and lost his medical license. According to NBC Montana, he was accused of negligent homicide and charged with 400 felony offenses related to illegal prescription drug distribution. Big Creek Family Medicine and Urgent Care, which was Dr. Christensen’s practice, has been closed.
Dr. Ibsen points out that his decision to stop treating chronic pain patients is showing solidarity. He supports Dr. Christensen and believes the regulatory environment is too hostile. Kate Lamport, who suffers from fibromyalgia and was one of Dr. Ibsen’s patients, is worried about the impact his decision will have on his practice. She mentions that it is difficult to find doctors who are willing to treat chronic pain and fibromyalgia.
Dr. Mark Ibsen was previously accused of over-prescribing pain medication to his patients. He believes that the Drug Enforcement Administration (DEA) is still investigating him. Although he denies the accusations, he admits the stress has made it difficult to work. He plans to take time off to reassess his career and practice.
Read more about fibromyalgia:
Memantine drug shows promise for fibromyalgia
Fibromyalgia study focuses on brain stimulation to fight pain